P. Faurie

Post-treatment positron emission tomography-computed tomography is highly predictive of outcome in Plasmablastic lymphoma

D. Mariano-Goulart, E. Gyan, G. Cartron, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Sarcoidosis and hepatitis C: clinical description of 11 cases

F. Zoulim, C. Broussolle, C. Trépo, 2010, European journal of gastroenterology & hepatology.

Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study

K. Hoang-Xuan, N. Martin-Duverneuil, J. Bay, 2017, Journal of Neuro-Oncology.

Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.

J. Blay, F. Ducray, P. Biron, 2017, European journal of cancer.

Array‐CGH predicts prognosis in plasma cell post‐transplantation lymphoproliferative disorders

G. Salles, F. Berger, E. Macintyre, 2017, Genes, chromosomes & cancer.

Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group

A. Delmer, P. Coppo, E. Gyan, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Sarcoidosis and lymphoma: a comparative study.

C. Broussolle, P. Sève, H. Ghesquières, 2015, QJM : monthly journal of the Association of Physicians.

Impact of the introduction of rituximab in first‐line follicular lymphoma: a retrospective study of 247 unselected patients referred to a single institution with a long‐term follow‐up

P. Biron, C. Sebban, C. Chassagne‐Clément, 2015, Hematological oncology.

Pattern of Care and Outcomes of Adolescent and Young Adults with Lymphoma Treated in the Rhône-Alpes Region.

G. Salles, F. Berger, P. Cony-Makhoul, 2019, Journal of adolescent and young adult oncology.